139 related articles for article (PubMed ID: 7679351)
1. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells.
Kato J; Misko TP; Currie MG
Eur J Pharmacol; 1993 Jan; 244(2):153-9. PubMed ID: 7679351
[TBL] [Abstract][Full Text] [Related]
2. Regulation of atrial natriuretic peptide receptors in vascular smooth muscle cells: role of cGMP.
Zhang LM; Tao H; Newman WH
Am J Physiol; 1993 Jun; 264(6 Pt 2):H1753-9. PubMed ID: 8391754
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells.
Cahill PA; Redmond EM; Foster C; Sitzmann JV
Eur J Pharmacol; 1995 Jan; 288(2):219-29. PubMed ID: 7536678
[TBL] [Abstract][Full Text] [Related]
5. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.
Kato J; Lanier-Smith KL; Currie MG
J Biol Chem; 1991 Aug; 266(22):14681-5. PubMed ID: 1650366
[TBL] [Abstract][Full Text] [Related]
6. Difference in effect of atrial natriuretic peptide on cGMP in aortic and coronary smooth muscle cells.
Newman WH; Kato J; Becker BF; Currie MG
Am J Physiol; 1992 Sep; 263(3 Pt 2):H710-4. PubMed ID: 1329536
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Beasley D; McGuiggin M
J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
[TBL] [Abstract][Full Text] [Related]
9. Human recombinant erythropoietin inhibits interleukin-1beta-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth-muscle cells.
Kusano E; Akimoto T; Inoue M; Masunaga Y; Umino T; Ono S; Ando Y; Homma S; Muto S; Komatsu N; Asano Y
Nephrol Dial Transplant; 1999 Mar; 14(3):597-603. PubMed ID: 10193805
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide enhances IL-1 beta-stimulated nitric oxide production in cultured rat vascular smooth muscle cells.
Iimura O; Kusano E; Homma S; Takeda S; Ikeda U; Shimada K; Asano Y
Kidney Blood Press Res; 1998; 21(1):36-41. PubMed ID: 9661135
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: influence on renin secretion.
Galle J; Schini VB; Stunz P; Wanner C; Schollmeyer P
Nephrol Dial Transplant; 1995; 10(2):191-7. PubMed ID: 7538649
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
Boese M; Busse R; Mülsch A; Schini-Kerth V
Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645
[TBL] [Abstract][Full Text] [Related]
13. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells.
Busse R; Mülsch A
FEBS Lett; 1990 Nov; 275(1-2):87-90. PubMed ID: 1702067
[TBL] [Abstract][Full Text] [Related]
14. Uptake of atrial natriuretic peptide and production of cGMP in cultured human glomerular endothelial cells.
Green DF; Duruibe VA; Blyden G; Laskey RE; Bourgoignie JJ
J Am Soc Nephrol; 1994 Oct; 5(4):1091-8. PubMed ID: 7849248
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
Papapetropoulos A; Abou-Mohamed G; Marczin N; Murad F; Caldwell RW; Catravas JD
Br J Pharmacol; 1996 Jul; 118(6):1359-66. PubMed ID: 8832057
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor.
Sabrane K; Gambaryan S; Brandes RP; Holtwick R; Voss M; Kuhn M
J Biol Chem; 2003 May; 278(20):17963-8. PubMed ID: 12637561
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide: a modulator for the epidermal growth factor receptor expression in developing ovarian granulosa cells.
Hattori M; Sakamoto K; Fujihara N; Kojima I
Am J Physiol; 1996 Mar; 270(3 Pt 1):C812-8. PubMed ID: 8638661
[TBL] [Abstract][Full Text] [Related]
19. Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors.
Papapetropoulos A; Marczin N; Catravas JD
Eur J Pharmacol; 1998 Mar; 344(2-3):313-21. PubMed ID: 9600668
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
Beasley D; Schwartz JH; Brenner BM
J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
